Amarin Corpの収益Y / Y
Amarin Corpの収益Y / Yは何ですか。
Amarin Corpの収益Y / Yは-23.53%です。
収益Y / Yの定義は何ですか。
過去3年間の年間収益の伸びは、過去3年間で平均した1年間の収益成長率です。
The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.
NASDAQのセクタHealth Careにおける収益Y / Yの企業と比べるAmarin Corp
Amarin Corpは何をしますか。
amarin corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. amarin's product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. vascepa® (icosapent ethyl) is amarin's first fda approved product and is available in the united states by prescription. for more information about vascepa visit www.vascepa.com.
Amarin Corpと類似の収益y / y
- Principal Incの収益Y / Yは-23.61%です。
- 17 Education & Technologyの収益Y / Yは-23.58%です。
- Columbia , Incの収益Y / Yは-23.57%です。
- Heartland USAの収益Y / Yは-23.55%です。
- Shanghai Junshi Biosciences Coの収益Y / Yは-23.54%です。
- Yangarra Resourcesの収益Y / Yは-23.54%です。
- Amarin Corpの収益Y / Yは-23.53%です。
- GMR Infrastructureの収益Y / Yは-23.51%です。
- Eastern Treadsの収益Y / Yは-23.50%です。
- Brookfield Property Partners L.Pの収益Y / Yは-23.50%です。
- Mesoblastの収益Y / Yは-23.48%です。
- GECI International S.Aの収益Y / Yは-23.43%です。
- DTE Coの収益Y / Yは-23.43%です。